Text reminders to help girls finish the HPV vaccine series in Kampala

SEARCH: SMS Electronic Adolescent Reminders for Completion of HPV vaccination- Uganda

NIH-funded research Columbia University Health Sciences · NIH-11397404

This project sends SMS reminders to preteen and adolescent girls and their caregivers in Kampala, Uganda to help them complete all HPV vaccine doses.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11397404 on NIH RePORTER

What this research studies

You or your daughter would receive periodic text-message reminders about upcoming HPV vaccine doses and where to get them. The work is carried out through three health centers and their linked schools and community immunization sites under Kampala Capital City Authority. The messages are designed to overcome common problems like school absenteeism, forgetting follow-up doses, and vaccine misperceptions by providing timely reminders and information. Researchers will follow vaccine records to see whether girls complete the required multi-dose HPV series.

Who could benefit from this research

Good fit: Ideal participants are preteen or adolescent girls in Kampala who are eligible for HPV vaccination and whose families have access to a working cell phone.

Not a fit: Girls who live outside the Kampala area, lack reliable phone access, or have already finished the HPV series are unlikely to benefit from enrolling.

Why it matters

Potential benefit: If successful, more girls would complete the HPV vaccine series, which could lower their future risk of cervical cancer.

How similar studies have performed: Text-message vaccine reminders have improved vaccine uptake in studies from high-income settings, but this approach has not been well tested among preteens and adolescents in sub-Saharan Africa.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.